[1]
I. O. Fedyak and O. V. Maksymenko, “Assessment of socio-economic availability of spironolactone diuretics (C03DA01) and furosemide (C03CA01) of the domestic pharmaceutical market”, Soc. pharm. health care, vol. 5, no. 1, pp. 20–30, Mar. 2019.